Published in Cancer Weekly, March 5th, 2002
The NCI has carefully considered the issues raised in the Lancet review. It has also considered the recent deliberations of the PDQ Screening and Prevention Editorial Board and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.